Liberate Bio
Today, the biggest bottleneck in genetic medicine isn’t the power of mRNA, CRISPR, or gene therapy—it’s that we can’t get these medicines anywhere but the liver. Our RAPTOR™ platform is the first AI-driven system that makes extrahepatic genetic medicine scalable. Unlike the slow, inefficient trial-and-error process that dominates biotech, we directly test hundreds of novel lipid nanoparticles (LNPs) in non-human primates (NHPs) at 100 times lower cost, generating real-world, human-relevant data.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
10
11 to 50 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 8 verified contacts at Liberate Bio
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- MD
Melissa Deck
Director of Platform · Other
EmailPhone - OL
Orna Lynch
Cellarity · Other
EmailPhone - SS
Stephen Scully
Co-founder, Interim CTO · Other
EmailPhone - WS
Walter Strapps
Chief Scientific Officer · Research & Development
EmailPhone - ML
Mark Larue
Associate Scientist · Research & Development
EmailPhone - AS
Alyssa Sanfilippo
Tessera Therapeutics · Other
EmailPhone
Showing 6 of 8 verified contacts
Top roles at Liberate Bio
6 distinct titles indexed · top 6 shown.
- 1associate scientist
- 1cellarity
- 1chief scientific officer
- 1co-founder, interim cto
- 1director of platform
- 1tessera therapeutics
Sign up to unlock all 8 contacts at Liberate Bio
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Liberate Bio
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.